Global Pharmaceutical News

MIT researchers repurpose cancer compound to treat PKD

Synendos receives EMA nod for brain therapy

Serac to present data from DETECT study

Stroke experts to test emerging nerve stimulation treatment

UCB announces MHRA approval for UCB’s Zilbrysq

Disco tunes into new cancer drug targets

StemSight and ERS Genomics focus on collaboration

Virtual reality training to help NHS doctors spot signs of sepsis

NHS catch up campaign launched for missed MMR vaccines

Poolbeg’s cytokine release syndrome drug shows potential

Researchers advance blood tests’ ability to detect cancer earlier

NHS to test new blood group genotyping test on inherited blood disorder patients

Zydus gets USFDA nod for generic medication

Researchers identify gene that causes heart defects in Down syndrome

PlaqueTec and Babraham Institute partner for treatment of coronary heart disease

Exclusive: Suspected fake Ozempic linked to three US cases of hypoglycemia

Amicus receives FDA approval for Pompe disease therapy

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

Fabre-Kramer gains FDA approval for major depressive disorder therapy

Germany to use controversial biomass amid energy crisis

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

European PFAS ban would burden drug companies and packagers

German government mulls limiting biofuel production

Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs